# Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005

> **NCT02271412** · PHASE1 · COMPLETED · sponsor: **Luye Pharma Group Ltd.** · enrollment: 58 (actual)

## Conditions studied

- Major Depressive Disorder, Recurrent, Unspecified

## Interventions

- **DRUG:** LY03005
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02271412
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271412, "Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02271412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*